Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?

Abhishek Singh, Anusha Chidharla, Nidhi Jain, Neha Debnath, Inshiya Dawoodi, Geetika Kukreja

Blood (2022) 140 (Supplement 1): 12520.

https://doi.org/10.1182/blood-2022-170630

Published: 2022

Journal Articles

A Single Dose of a Novel Anti-Human CD117-Amanitin Antibody Drug Conjugate (ADC) Engineered for a Short Half-Life Provides Dual Conditioning and Anti-Leukemic Activity and Extends Survival Compared to Standard of Care in Multiple Preclinical Models of Acute Myeloid Leukemia (AML)

Leanne Lanieri, Tahirih L Lamothe, BS, Oliver Miske, Sean M McDonough, Ganapathy N Sarma, Prashant Bhattarai, Kellie Latimer, Junia Dushime, Nidhi Jain, Rahul Palchaudhuri, PhD, Ryan Knihtila, Bradley R Pearse, PhD, Jennifer L Proctor, BS, Anthony E Boitano, PhD, Michael P Cooke, PhD, John C. Davis, Jr., MD MPH, MS

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-140422

Published: 2020

Journal Articles

Relationship of Baseline Tumor Angiogenesis with Kinetics of Inflammatory Markers in DLBCL

Gaurav Prakash, MD DM, Vaishali Aggarwal, Nidhi Jain, MD, Amanjit Bal, MD, Manupdesh Singh Sachdeva, MD, Pankaj Malhotra, MD MBBS, Alka Khadwal, MD, Vikas Suri, MD, Savita Kumari, MD DM, Ashim Das, MD, Subhash Varma, MBBS, MD Professor & Head, Sub Dean

Blood (2015) 126 (23): 5056.

https://doi.org/10.1182/blood.V126.23.5056.5056

Published: 2015

Journal Articles

Improved Outcome of AYA-CML Even in Resource Constraints Settings

Uday Yanamandra, MBBS, MD DNB, Kamal Kant Sahu, MD, Nidhi Jain, MBBS, MD, Shano Naseem, MBBS, MD, Alka Khadwal, MD, Prakash Gaurav, MBBS, MD DM, Neelam Varma, MBBS, MD, Subhash Varma, MBBS, MD, Pankaj Malhotra, MBBS, MD

Blood (2014) 124 (21): 2615.

https://doi.org/10.1182/blood.V124.21.2615.2615

Published: 2014

Journal Articles

Ethnic Disparities in Chronic Lymphocytic Leukemia Survival: A SEER Database Review

Sikander Ailawadhi, MD, Dongyun Yang, PhD, Nidhi Jain, MD, Mie Mie Thinn, MBBS, Wendy Cozen, D.O., M.P.H., Asher Chanan-Khan, MD

Blood (2012) 120 (21): 757.

https://doi.org/10.1182/blood.V120.21.757.757

Published: 2012

Journal Articles

Explaining the Excess Risk of Multiple Myeloma in African-Americans

Blood (2012) 120 (21): 4002.

https://doi.org/10.1182/blood.V120.21.4002.4002

Published: 2012

NARROW

IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?

A Single Dose of a Novel Anti-Human CD117-Amanitin Antibody Drug Conjugate (ADC) Engineered for a Short Half-Life Provides Dual Conditioning and Anti-Leukemic Activity and Extends Survival Compared to Standard of Care in Multiple Preclinical Models of Acute Myeloid Leukemia (AML)

Relationship of Baseline Tumor Angiogenesis with Kinetics of Inflammatory Markers in DLBCL

Improved Outcome of AYA-CML Even in Resource Constraints Settings

Ethnic Disparities in Chronic Lymphocytic Leukemia Survival: A SEER Database Review

Explaining the Excess Risk of Multiple Myeloma in African-Americans

Email alerts

ASH Publications

American Society of Hematology

IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?

A Single Dose of a Novel Anti-Human CD117-Amanitin Antibody Drug Conjugate (ADC) Engineered for a Short Half-Life Provides Dual Conditioning and Anti-Leukemic Activity and Extends Survival Compared to Standard of Care in Multiple Preclinical Models of Acute Myeloid Leukemia (AML)

Relationship of Baseline Tumor Angiogenesis with Kinetics of Inflammatory Markers in DLBCL

Improved Outcome of AYA-CML Even in Resource Constraints Settings

Ethnic Disparities in Chronic Lymphocytic Leukemia Survival: A SEER Database Review

Explaining the Excess Risk of Multiple Myeloma in African-Americans

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only